Search

Your search keyword '"De Propris, M"' showing total 3 results
Start Over Author "De Propris, M" Topic letters to the editor
3 results on '"De Propris, M"'

1. Efficacy of rituximab treatment in postpartum acquired haemophilia A.

Author

SANTORO, C., RAGO, A., BIONDO, F., DE PROPRIS, M. S., DE VELLIS, A., GUARINI, A., PIGNOLONI, P., and MAZZUCCONI, MARIA G.

Subjects
LETTERS to the editor, RITUXIMAB
Abstract

A letter to the editor is presented in response to the article regarding the effectiveness of rituximab treatment in postpartum acquired haemophilia A.

Published
2008
Full Text
View/download PDF

2. Biclonal blast crisis with a mutated ABL catalytic domain in a Ph, del (9q)-positive CML patient responsive to imatinib: drug resistance should be monitored in all patients irrespective of response status.

Author

Alimena, G., Breccia, M., Mancini, M., Diverio, D., Nanni, M., De Propris, M. S., Cimino, G., Pane, F., and Mandelli, F.

Subjects
LETTERS to the editor, DRUG resistance in cancer cells, LEUKEMIA, PATIENTS
Abstract

Presents a letter to the editor about monitoring of drug resistance in all leukemia patients irrespective of response status.

Published
2005
Full Text
View/download PDF

3. High rate of MRD-responses in young and fit patients with IGHV mutated chronic lymphocytic leukemia treated with front-line fludarabine, cyclophosphamide, and intensified dose of ofatumumab (FCO2)

Author

Caterina Musolino, Francesco Albano, Emanuele Angelucci, Francesca Romana Mauro, Fiorella Ilariucci, Alessandra Tedeschi, Sara Raponi, Roberta Battistini, Antonio Cuneo, Francesco Zaja, Stefano Soddu, Gianluigi Reda, Alessandro Gozzetti, Alfonso Piciocchi, Marta Coscia, Antonino Neri, Francesca Re, Anna Marina Liberati, Daniela Pietrasanta, Mauro Nanni, Anna Guarini, Maria Stefania De Propris, Robin Foà, Irene Della Starza, Ilaria Del Giudice, Stefano Molica, Marco Vignetti, Giovanni Del Poeta, Mauro, Fr, Molica, S, Soddu, S, Ilariucci, F, Coscia, M, Zaja, F, Angelucci, E, Re, F, Liberati, Am, Tedeschi, A, Reda, G, Pietrasanta, D, Gozzetti, A, Battistini, R, Del Poeta, G, Musolino, C, Nanni, M, Piciocchi, A, Vignetti, M, Neri, A, Albano, F, Cuneo, A, Del Giudice, I, Della Starza, I, De Propris, M, Raponi, S, Guarini, Ar, and Foà, R.

Subjects
Oncology, medicine.medical_specialty, Cyclophosphamide, Chronic lymphocytic leukemia, Lymphoproliferative disorders, Ofatumumab, Antibodies, Monoclonal, Humanized, NO, chemistry.chemical_compound, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Chronic Lymphocytic Leukemia, Letters to the Editor, Minimal Residual Disease, Lymphoproliferative Disorders, business.industry, Front line, Hematology, medicine.disease, Settore MED/15, Minimal residual disease, Leukemia, Lymphocytic, Chronic, B-Cell, Fludarabine, Treatment Outcome, chemistry, N/A, Chronic Lymphocytic Leukemia, Lymphoproliferative Disorders, IGHV@, business, Rituximab, Vidarabine, medicine.drug
Abstract

N/A

Published
2020

Catalog

Books, media, physical & digital resources
See catalog results